Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosaku Nitta

Showing results (441-450 of 534) with videos related to

Pageof 54
Sort By:
Kidney360|April 4, 2022
Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A NephropathyTakahito Moriyama, Kazunori Karasawa, Yoei Miyabe, et al.
Blood Purification|July 17, 2019
A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover TrialMichio Mineshima, Susumu Takahashi, Tadashi Tomo, et al.
Clinical Kidney Journal|February 14, 2025
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC studyTakahiro Imaizumi, Hirotaka Komaba, Takayuki Hamano, et al.
Scientific Reports|February 12, 2021
Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathyYoei Miyabe, Kazunori Karasawa, Kenichi Akiyama, et al.
Immunogenetics|June 2, 2006
Functional impact of IgA nephropathy-associated selectin gene haplotype on leukocyte-endothelial interactionTakashi Takei, Megumi Hiraoka, Kosaku Nitta, et al.
CEN Case Reports|June 30, 2018
A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infectionTaro Akihisa, Ayami Ino, Hiroto Egawa, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2020
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry DiseaseYumi Aoyama, Yusuke Ushio, Takashi Yokoyama, et al.
Renal Replacement Therapy|September 14, 2022
Activity of daily life dependency predicts the risk of mortality in patients with COVID-19 undergoing hemodialysis: a retrospective analysis of a single center with nosocomial outbreakJun Ino, Fumika Iemura, Chihiro Nakajima, et al.
Hepatology International|April 3, 2021
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney diseaseHiroshi Kataoka, Saki Watanabe, Masayo Sato, et al.
Clinical Kidney Journal|July 11, 2024
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomesNahid Tabibzadeh, Dongyu Wang, Angelo Karaboyas, et al.
Pageof 54

Showing results (441-450 of 534) with videos related to

Sort By:
Pageof 54
Kidney360|April 4, 2022
Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A NephropathyTakahito Moriyama, Kazunori Karasawa, Yoei Miyabe, et al.
Blood Purification|July 17, 2019
A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover TrialMichio Mineshima, Susumu Takahashi, Tadashi Tomo, et al.
Clinical Kidney Journal|February 14, 2025
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC studyTakahiro Imaizumi, Hirotaka Komaba, Takayuki Hamano, et al.
Scientific Reports|February 12, 2021
Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathyYoei Miyabe, Kazunori Karasawa, Kenichi Akiyama, et al.
Immunogenetics|June 2, 2006
Functional impact of IgA nephropathy-associated selectin gene haplotype on leukocyte-endothelial interactionTakashi Takei, Megumi Hiraoka, Kosaku Nitta, et al.
CEN Case Reports|June 30, 2018
A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infectionTaro Akihisa, Ayami Ino, Hiroto Egawa, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2020
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry DiseaseYumi Aoyama, Yusuke Ushio, Takashi Yokoyama, et al.
Renal Replacement Therapy|September 14, 2022
Activity of daily life dependency predicts the risk of mortality in patients with COVID-19 undergoing hemodialysis: a retrospective analysis of a single center with nosocomial outbreakJun Ino, Fumika Iemura, Chihiro Nakajima, et al.
Hepatology International|April 3, 2021
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney diseaseHiroshi Kataoka, Saki Watanabe, Masayo Sato, et al.
Clinical Kidney Journal|July 11, 2024
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomesNahid Tabibzadeh, Dongyu Wang, Angelo Karaboyas, et al.
Pageof 54